Galecto Biotech is a startup based in France, 1 tracked investor.
Galecto Biotech is a startup founded in 2010 based in France. Brouky records 1 investor associated with the company.
Galecto Biotech develops treatments targeting fibrotic diseases and cancer by focusing on the modulation of galectin proteins to inhibit abnormal tissue scarring and tumor progression.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.